Loading clinical trials...
Loading clinical trials...
This trial is conducted in Europe and North America. The aim of this trial is to compare the effect on blood sugar control of liraglutide or sitagliptin, both in combination with metformin, in subject...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07224321 · Type 1 Diabetes Mellitus
NCT07395050 · Stage 3 Type 1 Diabetes
NCT01399385 · Healthy, Obesity, and more
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
Novo Nordisk Investigational Site
Birmingham, Alabama
Novo Nordisk Investigational Site
Escondido, California
Novo Nordisk Investigational Site
Fresno, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions